Skip to Main Content

Parkinson's Disease: Can Tech and Stem Cells Transform Treatment?

With guest Ihtsham ul Haq, M.D.
Ihtsham ul Haq, M.D.
Ihtsham ul Haq, M.D.

August 6, 2025

Guest: Ihtsham ul Haq, M.D.
Listen Time: 30m 28s

Can a lab-developed protein offer a long-term solution for treating autoimmune diseases?

Parkinson’s Disease, the second-most common #neurodegenerative disorder in the United States, is marked by the gradual loss of dopamine-producing neurons in the brain. The earliest signs are subtle motor changes that can precede a clinical diagnosis by years but are often difficult to detect with the naked eye.

That’s where artificial intelligence could make a transformative difference.

On this episode of Inside U Miami Medicine, Ihtsham ul Haq, M.D., chief of the Movement Disorders Division at the University of Miami Miller School of Medicine, shared how he and his team are using artificial intelligence to bring greater objectivity, consistency and speed to Parkinson’s diagnoses.

Listen on Apple Listen on iHeart Listen on Spotify

 
Ihtsham Haq

Ihtsham ul Haq, M.D., FAAN

Professor of Neurology, Movement Disorders
Clinical Profile | Publications
Biography: Dr. Ihtsham ul Haq is Professor of Neurology and Chief of Movement Disorders Division. His passion for the study of the brain began at Columbia University, at which he completed degrees in Bioengineering and in Philosophy. He obtained his medical degree at SUNY Downstate and his Neurology residency training at Georgetown University. After his residency he spent three years...
View Full Profile >